LYZL6
gene geneOn this page
Also known as LYC1PRO1485TKAL754
Summary
LYZL6 (lysozyme like 6, HGNC:29614) is a protein-coding gene on chromosome 17q12, encoding Lysozyme-like protein 6 (O75951). May be involved sperm-egg plasma membrane adhesion and fusion during fertilization.
This gene encodes a member of the C-type lysozyme/alpha-lactalbumin family. C-type lysozymes are bacteriolytic factors that play a role in host defense, whereas alpha-lactalbumins mediate lactose biosynthesis. The encoded protein contains catalytic residues characteristic of C-type lysozymes and may play a role in male reproduction. Alternatively spliced transcript variants have been observed for this gene.
Source: NCBI Gene 57151 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 24 total
- MANE Select transcript:
NM_020426
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:29614 |
| Approved symbol | LYZL6 |
| Name | lysozyme like 6 |
| Location | 17q12 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | LYC1, PRO1485, TKAL754 |
| Ensembl gene | ENSG00000275722 |
| Ensembl biotype | protein_coding |
| OMIM | 612751 |
| Entrez | 57151 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 protein_coding
ENST00000615905, ENST00000617692, ENST00000618542
RefSeq mRNA: 2 — MANE Select: NM_020426
NM_001199951, NM_020426
CCDS: CCDS11302
Canonical transcript exons
ENST00000615905 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003713109 | 35936755 | 35936833 |
| ENSE00003719858 | 35943567 | 35943713 |
| ENSE00003734437 | 35934518 | 35934865 |
| ENSE00003743440 | 35939218 | 35939558 |
| ENSE00003748493 | 35937758 | 35937916 |
Expression profiles
Bgee: expression breadth broad, 39 present calls, max score 90.95.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0243 / max 23.0053, expressed in 3 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 165408 | 0.0153 | 3 |
| 165411 | 0.0089 | 3 |
Top tissues by expression
100 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 90.95 | gold quality |
| right testis | UBERON:0004534 | 90.60 | gold quality |
| testis | UBERON:0000473 | 90.55 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 89.29 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 54.79 | gold quality |
| sural nerve | UBERON:0015488 | 42.59 | silver quality |
| granulocyte | CL:0000094 | 37.94 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| liver | UBERON:0002107 | 36.16 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| right lobe of liver | UBERON:0001114 | 35.14 | silver quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| vermiform appendix | UBERON:0001154 | 33.33 | silver quality |
| blood | UBERON:0000178 | 33.23 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| urinary bladder | UBERON:0001255 | 31.37 | silver quality |
| leukocyte | CL:0000738 | 31.15 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| monocyte | CL:0000576 | 30.84 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| tonsil | UBERON:0002372 | 29.07 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.04 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 27.59 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 27.32 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.32 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
28 targeting LYZL6, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4747-5P | 100.00 | 67.90 | 2681 |
| HSA-MIR-5196-5P | 100.00 | 67.98 | 2761 |
| HSA-MIR-4283 | 100.00 | 66.42 | 2097 |
| HSA-MIR-12118 | 100.00 | 65.88 | 1270 |
| HSA-MIR-3185 | 99.99 | 68.12 | 1959 |
| HSA-MIR-223-3P | 99.99 | 70.14 | 1140 |
| HSA-MIR-6891-5P | 99.98 | 66.53 | 1372 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-MIR-3173-3P | 99.98 | 66.49 | 1217 |
| HSA-MIR-4319 | 99.76 | 69.83 | 2586 |
| HSA-MIR-10393-3P | 99.72 | 66.56 | 961 |
| HSA-MIR-6801-5P | 99.72 | 66.50 | 981 |
| HSA-MIR-5004-5P | 99.68 | 66.63 | 1294 |
| HSA-MIR-3202 | 99.66 | 67.70 | 2737 |
| HSA-MIR-4328 | 99.57 | 71.06 | 4094 |
| HSA-MIR-671-5P | 99.52 | 67.11 | 1277 |
| HSA-MIR-3612 | 99.45 | 66.02 | 1333 |
| HSA-MIR-650 | 99.45 | 65.77 | 1309 |
| HSA-MIR-125A-5P | 99.36 | 70.59 | 1640 |
| HSA-MIR-125B-5P | 99.36 | 70.36 | 1662 |
| HSA-MIR-3678-3P | 99.31 | 67.10 | 1432 |
| HSA-MIR-10522-5P | 99.26 | 68.50 | 2087 |
| HSA-MIR-4795-5P | 99.11 | 66.90 | 876 |
| HSA-MIR-6871-5P | 98.90 | 66.67 | 671 |
| HSA-MIR-9500 | 98.62 | 66.54 | 1845 |
| HSA-MIR-4443 | 98.02 | 66.25 | 1928 |
| HSA-MIR-7847-3P | 96.63 | 64.58 | 952 |
Literature-anchored findings (GeneRIF, showing 1)
- LYZL6, an acidic, bacteriolytic and human sperm-related protein, is likely important for fertilization but not for the innate immunity of the male reproductive tract. (PMID:28182716)
Cross-species orthologs
14 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Lyzl6 | ENSMUSG00000020945 |
| rattus_norvegicus | Lyzl6 | ENSRNOG00000003501 |
| drosophila_melanogaster | LysB | FBGN0004425 |
| drosophila_melanogaster | LysD | FBGN0004427 |
| drosophila_melanogaster | LysE | FBGN0004428 |
| drosophila_melanogaster | LysP | FBGN0004429 |
| drosophila_melanogaster | LysS | FBGN0004430 |
| drosophila_melanogaster | LysX | FBGN0004431 |
| drosophila_melanogaster | CG16756 | FBGN0029765 |
| drosophila_melanogaster | CG7798 | FBGN0034092 |
| drosophila_melanogaster | CG16799 | FBGN0034538 |
| drosophila_melanogaster | CG11159 | FBGN0034539 |
| drosophila_melanogaster | CG8492 | FBGN0035813 |
| drosophila_melanogaster | CG30062 | FBGN0050062 |
Paralogs (8): LYZ (ENSG00000090382), LYZL1 (ENSG00000120563), SPACA3 (ENSG00000141316), LYZL2 (ENSG00000151033), LYZL4 (ENSG00000157093), LALBA (ENSG00000167531), SPACA5B (ENSG00000171478), SPACA5 (ENSG00000171489)
Protein
Protein identifiers
Lysozyme-like protein 6 — O75951 (reviewed: O75951)
All UniProt accessions (3): O75951, A0A080YUZ6, A0A087WXX7
UniProt curated annotations — full annotation on UniProt →
Function. May be involved sperm-egg plasma membrane adhesion and fusion during fertilization. Exhibits bacteriolytic activity in vitro against Micrococcus luteus and Staphylococcus aureus. Shows weak bacteriolytic activity against Gram-positive bacteria at physiological pH. Bacteriolytic activity is pH-dependent, with a maximum at around pH 5.6.
Subunit / interactions. Monomer.
Subcellular location. Secreted. Cell surface. Cell projection. Cilium. Flagellum.
Tissue specificity. Expressed in testis, epididymis and spermatozoa (at protein level). Expressed in late-stage spermatocytes and round spermatids.
Similarity. Belongs to the glycosyl hydrolase 22 family.
RefSeq proteins (2): NP_001186880, NP_065159* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000974 | Glyco_hydro_22_lys | Family |
| IPR001916 | Glyco_hydro_22 | Family |
| IPR019799 | Glyco_hydro_22_CS | Domain |
| IPR023346 | Lysozyme-like_dom_sf | Homologous_superfamily |
Pfam: PF00062
UniProt features (10 total): disulfide bond 4, active site 2, signal peptide 1, chain 1, domain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O75951-F1 | 92.84 | 0.86 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (2): 54; 71
Disulfide bonds (4): 25–145, 49–133, 83–98, 94–112
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 70 (showing top):
GOBP_SINGLE_FERTILIZATION, GOCC_SECRETORY_GRANULE, GOBP_MEMBRANE_FUSION, GOBP_PLASMA_MEMBRANE_ORGANIZATION, GOCC_CELL_SURFACE, GGGTGGRR_PAX4_03, SHEPARD_BMYB_MORPHOLINO_DN, MODULE_205, GOBP_CELLULAR_PROCESS_INVOLVED_IN_REPRODUCTION_IN_MULTICELLULAR_ORGANISM, GOBP_ENDOMEMBRANE_SYSTEM_ORGANIZATION, GOBP_PLASMA_MEMBRANE_FUSION, MORF_PDPK1, GOBP_MEMBRANE_ORGANIZATION, GOBP_FERTILIZATION, GOBP_DEFENSE_RESPONSE_TO_BACTERIUM
GO Biological Process (5): fusion of sperm to egg plasma membrane involved in single fertilization (GO:0007342), fertilization (GO:0009566), killing of cells of another organism (GO:0031640), defense response to bacterium (GO:0042742), single fertilization (GO:0007338)
GO Molecular Function (4): lysozyme activity (GO:0003796), catalytic activity (GO:0003824), hydrolase activity (GO:0016787), hydrolase activity, acting on glycosyl bonds (GO:0016798)
GO Cellular Component (9): acrosomal vesicle (GO:0001669), extracellular region (GO:0005576), cell surface (GO:0009986), sperm flagellum (GO:0036126), sperm midpiece (GO:0097225), sperm plasma membrane (GO:0097524), cilium (GO:0005929), motile cilium (GO:0031514), cell projection (GO:0042995)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 4 |
| single fertilization | 1 |
| cellular process involved in reproduction in multicellular organism | 1 |
| sexual reproduction | 1 |
| reproductive process | 1 |
| cell killing | 1 |
| disruption of cell in another organism | 1 |
| defense response | 1 |
| response to bacterium | 1 |
| fertilization | 1 |
| hydrolase activity, hydrolyzing O-glycosyl compounds | 1 |
| peptidoglycan muralytic activity | 1 |
| molecular_function | 1 |
| catalytic activity | 1 |
| hydrolase activity | 1 |
| secretory granule | 1 |
| 9+2 motile cilium | 1 |
| sperm flagellum | 1 |
| plasma membrane | 1 |
| intraciliary transport particle | 1 |
| membrane-bounded organelle | 1 |
| plasma membrane bounded cell projection | 1 |
| cilium | 1 |
Protein interactions and networks
STRING
482 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| LYZL6 | C12orf71 | A8MTZ7 | 531 |
| LYZL6 | ASTL | Q6HA08 | 479 |
| LYZL6 | ANKRD27 | Q96NW4 | 472 |
| LYZL6 | TEX38 | Q6PEX7 | 459 |
| LYZL6 | SCP2D1 | Q9UJQ7 | 447 |
| LYZL6 | SPRYD4 | Q8WW59 | 443 |
| LYZL6 | SPATA31F1 | Q6ZU69 | 432 |
| LYZL6 | PRR30 | Q53SZ7 | 430 |
| LYZL6 | CIMIP2A | Q6J272 | 422 |
| LYZL6 | CIMIP4 | O43247 | 418 |
| LYZL6 | MEGF8 | Q7Z7M0 | 384 |
| LYZL6 | CPM | P14384 | 380 |
| LYZL6 | GARIN1B | Q96KD3 | 374 |
| LYZL6 | YEATS4 | O95619 | 371 |
| LYZL6 | MIP | P30301 | 370 |
IntAct
6 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| LYZL6 | COL6A1 | psi-mi:“MI:0914”(association) | 0.530 |
| LYZL6 | rep | psi-mi:“MI:0915”(physical association) | 0.370 |
| ECE1 | LYZL6 | psi-mi:“MI:0915”(physical association) | 0.370 |
| LYZL6 | PLXNA2 | psi-mi:“MI:0914”(association) | 0.350 |
| LYZL6 | CLGN | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (33): TYW3 (Affinity Capture-MS), TMEM132A (Affinity Capture-MS), POGLUT1 (Affinity Capture-MS), SLC25A30 (Affinity Capture-MS), SLC16A10 (Affinity Capture-MS), PLXNA2 (Affinity Capture-MS), TUBB8 (Affinity Capture-MS), VSIG8 (Affinity Capture-MS), EOGT (Affinity Capture-MS), FKBP14 (Affinity Capture-MS), TMEM2 (Affinity Capture-MS), SEMG1 (Affinity Capture-MS), SEMG2 (Affinity Capture-MS), CTSF (Affinity Capture-MS), ATP12A (Affinity Capture-MS)
ESM2 similar proteins: A2AE20, C0HLB7, C1IIX1, D4ABW7, D9J142, D9J143, G3XDT7, O75951, P00702, P00709, P00710, P00711, P00712, P00713, P00714, P00716, P05105, P07458, P08334, P08896, P09462, P11375, P11376, P12065, P18137, P28546, P29752, P30805, P37161, P48816, P50717, P50718, P51782, P61944, P81646, P81708, P85045, Q06655, Q29145, Q29RT1
Diamond homologs: A0JNM6, A2AE20, A6QQ77, B6VH75, B6VH76, G3XDT7, O75951, P00697, P00698, P00699, P00700, P00701, P00702, P00703, P00704, P00705, P00706, P00707, P00708, P04421, P08905, P11375, P11376, P11941, P12066, P12067, P12068, P12069, P16973, P17607, P17897, P19849, P22910, P24364, P24533, P30201, P37712, P37713, P49663, P61626
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
24 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 20 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
739 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:35936685:A:AC | donor_gain | 1.0000 |
| 17:35936685:ACTG:A | donor_gain | 1.0000 |
| 17:35936686:C:CC | donor_gain | 1.0000 |
| 17:35936686:CTGC:C | donor_gain | 1.0000 |
| 17:35936706:T:TA | donor_gain | 1.0000 |
| 17:35936834:C:CC | acceptor_gain | 1.0000 |
| 17:35937916:CCT:C | acceptor_gain | 1.0000 |
| 17:35937918:T:C | acceptor_gain | 1.0000 |
| 17:35936676:T:TA | donor_gain | 0.9900 |
| 17:35936685:ACTGC:A | donor_gain | 0.9900 |
| 17:35936686:CTG:C | donor_gain | 0.9900 |
| 17:35936686:CTGCC:C | donor_gain | 0.9900 |
| 17:35936688:G:GA | donor_gain | 0.9900 |
| 17:35936689:C:A | donor_gain | 0.9900 |
| 17:35936709:T:TA | donor_gain | 0.9900 |
| 17:35936748:T:TA | donor_gain | 0.9900 |
| 17:35936831:GAT:G | acceptor_gain | 0.9900 |
| 17:35936833:TC:T | acceptor_loss | 0.9900 |
| 17:35936834:C:CG | acceptor_loss | 0.9900 |
| 17:35937915:CCCT:C | acceptor_gain | 0.9900 |
| 17:35936829:CAGAT:C | acceptor_gain | 0.9800 |
| 17:35937792:A:C | donor_gain | 0.9800 |
| 17:35937912:CAGCC:C | acceptor_gain | 0.9800 |
| 17:35942571:T:A | donor_gain | 0.9800 |
| 17:35937918:T:TC | acceptor_gain | 0.9700 |
| 17:35943562:CTTA:C | donor_loss | 0.9700 |
| 17:35943566:C:CA | donor_loss | 0.9700 |
| 17:35934864:CC:C | acceptor_gain | 0.9600 |
| 17:35934865:CC:C | acceptor_gain | 0.9600 |
| 17:35936786:T:A | donor_gain | 0.9600 |
AlphaMissense
982 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:35934856:C:A | W129C | 0.968 |
| 17:35934856:C:G | W129C | 0.968 |
| 17:35934865:C:A | W126C | 0.968 |
| 17:35934865:C:G | W126C | 0.968 |
| 17:35937832:A:C | F75C | 0.965 |
| 17:35937891:G:C | S55R | 0.956 |
| 17:35937891:G:T | S55R | 0.956 |
| 17:35937893:T:G | S55R | 0.956 |
| 17:35937819:G:C | S79R | 0.949 |
| 17:35937819:G:T | S79R | 0.949 |
| 17:35937821:T:G | S79R | 0.949 |
| 17:35937808:C:G | C83S | 0.946 |
| 17:35937809:A:T | C83S | 0.946 |
| 17:35937915:C:A | W47C | 0.945 |
| 17:35937915:C:G | W47C | 0.945 |
| 17:35936790:T:A | K114N | 0.944 |
| 17:35936790:T:G | K114N | 0.944 |
| 17:35937892:C:A | S55I | 0.939 |
| 17:35934820:C:A | W141C | 0.937 |
| 17:35934820:C:G | W141C | 0.937 |
| 17:35937900:A:C | F52L | 0.934 |
| 17:35937900:A:T | F52L | 0.934 |
| 17:35937902:A:G | F52L | 0.934 |
| 17:35937885:G:C | F57L | 0.933 |
| 17:35937885:G:T | F57L | 0.933 |
| 17:35937887:A:G | F57L | 0.933 |
| 17:35937832:A:G | F75S | 0.927 |
| 17:35939240:A:C | F39L | 0.926 |
| 17:35939240:A:T | F39L | 0.926 |
| 17:35939242:A:G | F39L | 0.926 |
dbSNP variants (sampled 300 via entrez): RS1000050714 (17:35942353 T>C), RS1000403681 (17:35942653 A>G), RS1000406439 (17:35935331 T>A,C), RS1000796156 (17:35934908 C>G,T), RS1000853683 (17:35939955 G>A), RS1000873860 (17:35941448 T>G), RS1001004427 (17:35941047 C>A,G), RS1001013387 (17:35945559 C>T), RS1001305766 (17:35939639 T>C), RS1001920820 (17:35944426 G>A), RS1002015576 (17:35944110 T>C), RS1002407179 (17:35939460 A>C), RS1002531869 (17:35944123 T>G), RS1002858361 (17:35937228 G>A), RS1002932122 (17:35943231 G>A,C,T)
Disease associations
OMIM: gene MIM:612751 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
11 total (human), top 11 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | increases expression, affects cotreatment | 3 |
| entinostat | increases expression, affects cotreatment | 2 |
| belinostat | increases expression, affects cotreatment | 2 |
| Panobinostat | affects cotreatment, increases expression | 2 |
| trichostatin A | increases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, increases expression | 1 |
| dorsomorphin | affects cotreatment, increases expression | 1 |
| Vorinostat | increases expression | 1 |
| Cyclosporine | increases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Antirheumatic Agents | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.